Results 221 to 230 of about 1,325,240 (268)
Some of the next articles are maybe not open access.
Perception of cardiovascular risk and comparison with actual cardiovascular risk
European Journal of Cardiovascular Prevention & Rehabilitation, 2009Current guidelines recommend treating patients according to their absolute cardiovascular disease (CVD) risk. We examined perception of CVD risk among adults and how it can be compared with actual CVD risk.The perception of CVD risk was assessed by two questions asking about participants' 'risk to get a heart attack or a stroke over the next 10 years ...
Alwan H +4 more
openaire +4 more sources
Cardiovascular Risk Assessment
Medical Clinics of North America, 2017Cardiovascular risk assessment is fundamental to prevention of cardiovascular disease, because it helps determine the size of the potential benefits that might accrue to individual patients from use of statins, aspirin, and other preventive interventions.
Mark J, Pletcher, Andrew E, Moran
openaire +2 more sources
Platelets and cardiovascular risk
Acta Cardiologica, 2017Atherosclerosis and its late sequels are still the number one cause of death in Western societies. Platelets are a driving force not only during the genesis of atherosclerosis, but especially in its late stages, as evidenced by complications such as arterial thrombosis, myocardial infarction, and ischaemic stroke.
Barbara, Renga, Franco, Scavizzi
openaire +2 more sources
Erythropoietin and Cardiovascular Risk
Blood Purification, 2008We studied the changes in some cardiovascular risk (CVR) factors in 24 maintenance hemodialysis patients treated for 1 year with recombinant human erythropoietin (rHuEPO) either intravenously (12 cases) or subcutaneously (12 cases). In order to clarify whether changes in some parameters were due to direct action of rHuEPO or to changes in food intake ...
V, Allegra +3 more
openaire +2 more sources
NSAIDs and cardiovascular risk
Journal of Cardiovascular Medicine, 2017NSAIDs are the most largely used class of drugs in the world, due to their large use in many diseases, in particular for the systemic inflammatory diseases. Nevertheless, today NSAIDs are less used for some of these diseases, due to several side-effects correlated to these drugs. The antiinflammatory mechanism of NSAIDs consist in the inibhition of two
Marsico F, Paolillo S, Filardi PP
openaire +3 more sources
Albuminuria and cardiovascular risk
Hipertensión y Riesgo Vascular, 2023Cardiovascular risk (CVR) estimation is a fundamental tool for guiding therapy. Albuminuria indicates target organ damage in an accessible, economic and non-invasive manner. Improves high-risk patient identification, especially in chronic kidney disease (CKD) and diabetes mellitus (DM). In addition, anti-albuminuric treatments may improve CVR.
D H, Rigo, P M, Jiménez, M, Orias
openaire +2 more sources
Rosiglitazone and cardiovascular risk
Current Atherosclerosis Reports, 2008A meta-analysis of 42 clinical trials suggested that rosiglitazone, a widely used thiazolidinedione, was associated with a 43% greater risk of myocardial infarction (P = 0.03) and a 64% greater risk of cardiovascular death (P = 0.06). However, a number of criticisms have been raised that potentially undermine the conclusions of this analysis.
Sanjay, Kaul, George A, Diamond
openaire +3 more sources
Annales d'Endocrinologie, 2021
Cardiovascular diseases remain the leading cause of non-communicable chronic diseases, are related to high morbidity and mortality and are associated to a huge impact on healthcare budgets. Biomarkers play an important role for the diagnosis and prognosis of cardiovascular diseases and are recognized tools for value-based care. Parathyroid hormone (PTH)
openaire +2 more sources
Cardiovascular diseases remain the leading cause of non-communicable chronic diseases, are related to high morbidity and mortality and are associated to a huge impact on healthcare budgets. Biomarkers play an important role for the diagnosis and prognosis of cardiovascular diseases and are recognized tools for value-based care. Parathyroid hormone (PTH)
openaire +2 more sources
Obesity and cardiovascular risk
Growth Hormone & IGF Research, 2003In most industrialized countries, 40-60% of the population is now overweight or obese. Obesity has recently been recognized as a major modifiable risk factor for cardiovascular disease, second only to cigarette smoking. Excess weight and obesity markedly increase the risk for hypertension, diabetes, coronary artery disease and congestive heart failure ...
openaire +2 more sources
Hyperuricemia and cardiovascular risk
High Blood Pressure & Cardiovascular Prevention, 2014There is an increasing prevalence of gout and hyperuricemia worldwide. Gout confers a significant individual and social burden and is increasingly recognized as a prevalent chronic disease state requiring appropriate long-term management. Gout and hyperuricemia appear to be independent risk factors for incident hypertension, renal disease and ...
Grassi D +4 more
openaire +4 more sources